SC 13G





Washington, D.C. 20549




Under the Securities Exchange Act of 1934

(Amendment No.     )*



Deciphera Pharmaceuticals, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)


(CUSIP Number)

December 31, 2017

(Date of Event which Requires filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)


* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




CUSIP No. 24344T101   Schedule 13G   Page 1 of 4 Pages  



Names of Reporting Persons


Brightstar Associates LLC


Check the Appropriate Box if a Member of a Group

(a)  ☐        (b)  ☐



SEC Use Only




Citizen or Place of Organization



Number of



Owned by






Sole Voting Power




Shared Voting Power




Sole Dispositive Power




Shared Dispositive Power




Aggregate Amount Beneficially Owned by Each Reporting Person




Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐




Percent of a Class Represented by Amount in Row 9




Type of Reporting Person


Limited Liability Company


CUSIP No. 24344T101   Schedule 13G   Page 2 of 4 Pages  


ITEM 1. (a)    Name of Issuer:

Deciphera Pharmaceuticals, Inc. (the “Issuer”).

(b)    Address of Issuer’s Principal Executive Offices:

500 Totten Pond Road

Waltham, MA 02451


ITEM 2. (a)    Name of Person Filing:

This statement is filed on behalf of Brightstar Associates LLC (the “Reporting Person”).

(b)    Address or Principal Business Office:

The business address of the Reporting Person is 1020 Central Street, Suite 300, Kansas City, Missouri 64105.

(c)    Citizenship of each Reporting Person is:

The Reporting Person is incorporated in the State of Missouri.

(d)    Title of Class of Securities:

Common Stock, par value $0.01 per share (the “Common Stock”).

(e)    CUSIP Number:



ITEM 3.     

Not applicable.


ITEM 4. Ownership

The ownership information presented below represents beneficial ownership of shares of Common Stock of the Issuer as of December 31, 2017, based upon 32,591,686 shares of Common Stock outstanding as of October 31, 2017.

(a)    Amount beneficially owned:

The Reporting Person is the record holder of 16,572,370 shares of Common Stock. The Reporting Person is managed by a three-person managing board consisting of Mark K. Fallon, Gary L. Muller and Timothy Fritzel, and all action relating to the voting or disposition of these shares requires approval of a majority of the board. Such individuals expressly disclaim any beneficial ownership over the shares held by the Reporting Person.

CUSIP No. 24344T101   Schedule 13G   Page 3 of 4 Pages  


(b)    Percent of class: 50.8%

(c)    Number of shares as to which the person has:

(i)    Sole power to vote or to direct the vote: 16,572,370

(ii)    Shared power to vote or direct the vote: 0

(iii)    Sole power to dispose or to direct the disposition of: 16,572,370

(iv)    Shared power to dispose or to direct the disposition of: 0


ITEM 5. Ownership of Five Percent or Less of a Class

Not applicable.


ITEM 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable.


ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.


ITEM 8. Identification and Classification of Members of the Group

Not applicable.


ITEM 9. Notice of Dissolution of Group

Not applicable.


ITEM 10. Certification

Not applicable.

CUSIP No. 24344T101   Schedule 13G   Page 4 of 4 Pages  



After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: January 26, 2018


Brightstar Associates LLC

/s/ Mark Fallon

Name:   Mark Fallon
Title:   Member – Board of Managers